Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/28/2008US20080207667 Use of nalbuphine and related compounds to treat symptoms of respiratory problems
08/28/2008US20080207666 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
08/28/2008US20080207665 Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidinopropanoic Acid Compounds as Orl-1-Receptor Antagonists
08/28/2008US20080207664 Uniform concentration in blood ; oral administering
08/28/2008US20080207663 Once daily dosage forms of trospium
08/28/2008US20080207662 Uniform blood concentration; sustained release; therapy for bladder disorders
08/28/2008US20080207661 Uniform blood concentration; oral administering
08/28/2008US20080207660 Antiallergens; antiinflammatory agents; drug abuse; cognition activators; psychological disorders; side effect reduction; aryl and heteroaryl pyrazole compounds
08/28/2008US20080207659 Inhibitors of phosphodiesterase type 4
08/28/2008US20080207658 Mixture of pyrimidylaminobenzamide and kinase inhibitor
08/28/2008US20080207657 Use Of Minoxidil Sulfate As An Anti-Tumor Drug
08/28/2008US20080207656 Methods, compositions, and kits for organ protection during systemic anticancer therapy
08/28/2008US20080207655 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/28/2008US20080207654 Therapy for circulatory diseases; metabolism disorders; central nervous system disorders; hypotensive agents; cardiovascular disorders; antidiabetic agents; Alzheimer's disease
08/28/2008US20080207652 Novel inhibitors of folic acid-dependent enzymes
08/28/2008US20080207651 Asthma therapy; antiallergens; antiinflammatory agents
08/28/2008US20080207650 Chemical Compounds 636
08/28/2008US20080207649 Method of treating brain ischemia
08/28/2008US20080207648 Organic Compounds
08/28/2008US20080207647 Pyrazole Derivatives Having Tyrosine Kinase Activity
08/28/2008US20080207646 Prevent collagen synthesis in liver cells; increase blood flow through portal vein; cirrhosis; long half-life
08/28/2008US20080207645 Phosphodiesterase inhibitor; therapy for asthma; chronic obstructive pulmnary disease; rheumatic arthritic; skin disorders; irritable bowel synthrome
08/28/2008US20080207644 Administering in mouth or mucous membrane; anticancer agents; administering phosphodiesterase inhibitor , map kinase inhibitor, proteasome inhibitor
08/28/2008US20080207643 Composition for Treating Hyperlipaemia
08/28/2008US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents
08/28/2008US20080207641 Immunosuppressants; antiallergens
08/28/2008US20080207640 Administering drug; anticancer agents; antitumor agents
08/28/2008US20080207639 Moderate binding of selectins ; chronic obstructive pulmonary disease; Crohn's disease; sepsis; antiinflammatory agents; skin disorders; antiarthritic agents; cardiovascular disorders; autoimmune diseases '
08/28/2008US20080207638 Compounds
08/28/2008US20080207637 Controlling triglyceride concentration; central nervous system disorders; psychological disorders; eating disordes; drug abuse; anticancer agents
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207635 Tyrosine kinase moderators; anticancer agents; antidiabetic agents; restenosis; arteriosclerosis ; skin disorders;
08/28/2008US20080207634 Chemical Compounds
08/28/2008US20080207633 Conjugated to polyoxyethylene glycol; analgesics; antidiabetic agents; anticancer agents; sleep disorders; antidepressants; anxiolytic agents
08/28/2008US20080207632 Protein kinase inhibitors
08/28/2008US20080207631 Administering adatanserin; analgesics; Parkinson's disease; amyotrophic lateral sclerosis; vision defects; antiepileptic agents; antihypoxic agents
08/28/2008US20080207630 2-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators
08/28/2008US20080207629 Liquid preparation comprising pimobendan
08/28/2008US20080207628 Methods of preventing and reducing the severity of stress-associated conditions
08/28/2008US20080207627 Methods of preventing and reducing the severity of stress-associated conditions
08/28/2008US20080207626 Storage stability; mixture of tetrahydrobiopterin and excipient
08/28/2008US20080207625 Synthesis and Purification of Pteroic Acid and Conjugates Thereof
08/28/2008US20080207624 Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
08/28/2008US20080207623 Peptide-enhanced corneal drug delivery
08/28/2008US20080207622 Soluble epoxide hydrolase inhibitors
08/28/2008US20080207621 Use treating hypertensive, cardiovascular, inflammatory, pulmonary, and diabetes-related diseases; compounds are aminosulfonylphenyl urea or thiourea e.g. 4-(3-Adamantan-1-yl-ureido)-N-(2-morpholin-4-yl-ethyl)-benzenesulfonamide
08/28/2008US20080207620 Modulators of pharmacokinetic properties of therapeutics
08/28/2008US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/28/2008US20080207618 6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor
08/28/2008US20080207617 Prevent autophosphorylation of tyrosine kinase; therapy for hematopoietic cancer; leukemia; myelodysplastic syndrome
08/28/2008US20080207616 Anticancer agents; for humans, animals
08/28/2008US20080207615 Using allelic variations in epidermal growth factor gene as evaluative tool in predicting positive response to anticancer agents, therapy; administering gefitinib
08/28/2008US20080207614 Quinazoline derivatives for the treatment and prevention of diabetes and obesity
08/28/2008US20080207613 Selective Kinase Inhibitors
08/28/2008US20080207612 Analgesics; pain management
08/28/2008US20080207611 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders
08/28/2008US20080207610 Aldh-2 inhibitors in the treatment of addiction
08/28/2008US20080207609 Anticancer agents; kinase inhibitor; immunotherapy; viricides; antiinflammatory agents
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008US20080207607 Antiarthritic agents; antiinflammatory agents; arteriosclerosis; multiple sclerosis
08/28/2008US20080207606 Immunology diseases; analgesics; antiarthritic agents; cardiovascular disorders; antiischemic agents; skin disorders;antiulcer agents; bone disorders; antihistamines
08/28/2008US20080207605 Administering combination of metalloproteinase and caspase inhibitors
08/28/2008US20080207604 Dtection compound that moderated tau-tau protein association; Alzheimer's disease; administering methylene blue
08/28/2008US20080207603 Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc)
08/28/2008US20080207602 Succinoylamino benzodiazepines as inhibitors of abeta protein production
08/28/2008US20080207601 Methods of and Compositions For the Prevention of Anxiety, Substance Abuse, and Dependence
08/28/2008US20080207600 Pharmaceutical Combination for the Treatment of Cns Functional Disorders
08/28/2008US20080207599 Use of Selective Chloride Channel Modulators to Treat Methamphetamine Abuse
08/28/2008US20080207598 Indole derivatives
08/28/2008US20080207597 Homopiperazine compounds that inhibit ribosomal frameshifting by binding to rna pseudoknot structure of sars coronavirus
08/28/2008US20080207596 Novel compounds 329
08/28/2008US20080207595 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
08/28/2008US20080207594 Glycogen synthase kinase inhibitor in mixture with immunomodulating agents; antidiabetic agents; immunosupprsants
08/28/2008US20080207593 Antihistamine Combination
08/28/2008US20080207592 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
08/28/2008US20080207591 Organic Compounds
08/28/2008US20080207590 Inhibitors of Histone Deacetylase
08/28/2008US20080207589 Cyclized derivatives as eg-5 inhibitors
08/28/2008US20080207588 Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines
08/28/2008US20080207587 Pyridazine Derivatives for Inhibiting Human Stearoyl-Coa-Desaturase
08/28/2008US20080207586 6-[1-Hydroxyethyl]-4-methyl-7-oxo-3[[-5-(sulfamoylaminomethyl)pyrrolidin-3-yl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid or S-4661; storage stability, antibiotics
08/28/2008US20080207585 Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
08/28/2008US20080207584 Compound Having S1P Receptor Binding Potency and Use Thereof
08/28/2008US20080207583 Process For Preparing Granulates Comprising Amoxicillin
08/28/2008US20080207582 Substituted Porphyrins
08/28/2008US20080207580 Method of treating immune pathologies with low dose estrogen
08/28/2008US20080207579 Uses of tetrahydrobiopterin and derivatives thereof
08/28/2008US20080207578 Inducing a cytostatic effect on cancer cells by administering cucurbitacin B or cucurbitacin D; industrial scale; antitumor agents; breast, brain, colon, ovarian, lung, prostate, and kidney cancer; melanoma, leukemia, retinoblastoma
08/28/2008US20080207577 Mixture of a P2X7 (purinergic) receptor antagonist, and a corticosteroid; 1-adamantylalkylamide derivatives with benzyl or pyridyl group; respiratory system disorders, chronic obstructive pulmonary disease; antiasthmatics; formoterol, budesonide; kits
08/28/2008US20080207576 Substituted sapogenins and their use
08/28/2008US20080207575 Catalytic oxidation of 17 alpha -(3-hydroxypropyl)-6 beta ,7 beta ,15 beta ,16 beta -dimethylene-5 beta -androstane-3 beta ,5,17 beta -triol using 2,2,6,6-tetramethylpiperidine-1-oxyl radical catalyst; adding protic acid; bromination, reacting with mesyl chloride, decyclization; contraceptives
08/28/2008US20080207574 Withanolides, probes and binding targets and methods of use thereof
08/28/2008US20080207573 Compounds for treating viral infections
08/28/2008US20080207572 Administering 2-aminoarylthiazole or 2-aminoaryloxazole derivative to treat relapsed or refractory multiple myeloma expressing FGFR3 (fibroblast growth factor receptor)
08/28/2008US20080207571 Regimens for Oral Monophasic Contraceptives
08/28/2008US20080207570 Clobetasol 17-propionate, desonide, or betamethaone valerate; emollient, wax, or fatty alcohol; nonionic surfactant; propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol, ethoxydiglycol, urea, acetone, or oleic acid propenetrating agent; nongreasy; psoriasis, skin disorders
08/28/2008US20080207569 Methods for the treatment of liver diseases
08/28/2008US20080207568 Class of Gamma Delta T Cells Activators and Use Thereof
08/28/2008US20080207567 Administering sphingosine-1-phosphate (S1P)modulator or agonist such as a (benzo)thiophene derivative; immunosuppression; hepatitis C virus infections
08/28/2008US20080207566 Methods for the administration of amifostine and related compounds
1 ... 3112 3113 3114 3115 3116 3117 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 3130 3131 3132 ... 7860